| Stage | AVGO | % of rev | GEN | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $29.6B | 100.00% | $1.4B | 100.00% | AVGO ×21.62 |
| Gross profit | $20.5B | 69.13% | $1.0B | 75.89% | GEN +6.8pp |
| Operating income | $16.0B | 53.92% | $507M | 37.03% | AVGO +16.9pp |
| Pre-tax income | $15.3B | 51.62% | $386M | 28.20% | AVGO +23.4pp |
| Net income | $13.1B | 44.23% | $287M | 20.96% | AVGO +23.3pp |
| Stage | AVGO | GEN | Gap · A − B |
|---|---|---|---|
| Revenue | $29.6B100.00% | $1.4B100.00% | AVGO ×21.62 |
| Gross profit | 69.13%$20.5B | 75.89%$1.0B | GEN +6.8pp |
| Operating income | 53.92%$16.0B | 37.03%$507M | AVGO +16.9pp |
| Pre-tax income | 51.62%$15.3B | 28.20%$386M | AVGO +23.4pp |
| Net income |
| 44.23%$13.1B |
| 20.96%$287M |
| AVGO +23.3pp |